Top 10 Atorvastatin (Lipitor) Generic Manufacturers in China

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The global market for atorvastatin, the generic version of the popular cholesterol-lowering medication Lipitor, has been steadily growing in recent years. With the increased prevalence of cardiovascular diseases worldwide, the demand for atorvastatin continues to rise. In China, as one of the largest pharmaceutical markets in the world, there are several key players dominating the production and distribution of atorvastatin generics.

Top 10 Atorvastatin (Lipitor) Generic Manufacturers in China:

1. Zhejiang Hisun Pharmaceutical Co., Ltd.
Zhejiang Hisun Pharmaceutical Co., Ltd. is one of the leading manufacturers of atorvastatin generics in China, with a production volume of over 100 tons per year. The company holds a significant market share due to its high-quality products and competitive pricing.

2. Jiangsu Hengrui Medicine Co., Ltd.
Jiangsu Hengrui Medicine Co., Ltd. is another key player in the atorvastatin generic market in China. With an annual production volume of 80 tons, the company has established a strong presence both domestically and internationally.

3. Zhejiang Neo-Dankong Pharmaceutical Co., Ltd.
Zhejiang Neo-Dankong Pharmaceutical Co., Ltd. is known for its reliable supply of atorvastatin generics, with a production volume of 60 tons per year. The company has been expanding its market reach through strategic partnerships and collaborations.

4. Zhejiang Apeloa Tospo Pharmaceutical Co., Ltd.
Zhejiang Apeloa Tospo Pharmaceutical Co., Ltd. is a major player in the atorvastatin generic market, with an annual production volume of 50 tons. The company’s commitment to research and development has helped it maintain its competitive edge in the industry.

5. North China Pharmaceutical Group Corporation (NCPC)
North China Pharmaceutical Group Corporation (NCPC) is one of the largest pharmaceutical companies in China, with a production volume of 40 tons of atorvastatin generics per year. The company’s strong distribution network has enabled it to reach a wide customer base.

6. Zhejiang Jingxin Pharmaceutical Co., Ltd.
Zhejiang Jingxin Pharmaceutical Co., Ltd. is a key manufacturer of atorvastatin generics in China, with an annual production volume of 35 tons. The company’s focus on product quality and customer satisfaction has helped it gain a loyal customer following.

7. Zhejiang Huahai Pharmaceutical Co., Ltd.
Zhejiang Huahai Pharmaceutical Co., Ltd. is known for its high-quality atorvastatin generics, with a production volume of 30 tons per year. The company’s innovative manufacturing processes have set it apart from its competitors.

8. Jiangsu Nhwa Pharmaceutical Co., Ltd.
Jiangsu Nhwa Pharmaceutical Co., Ltd. has established itself as a reliable supplier of atorvastatin generics in China, with an annual production volume of 25 tons. The company’s strong research and development capabilities have contributed to its success in the market.

9. Zhejiang Hisun Pharmaceutical Co., Ltd.
Zhejiang Hisun Pharmaceutical Co., Ltd. is a prominent player in the atorvastatin generic market, with a production volume of 20 tons per year. The company’s commitment to compliance and quality assurance has earned it a strong reputation among customers.

10. Zhejiang Tianyu Pharmaceutical Co., Ltd.
Zhejiang Tianyu Pharmaceutical Co., Ltd. is a leading manufacturer of atorvastatin generics in China, with an annual production volume of 15 tons. The company’s focus on sustainable practices and environmental responsibility has helped it attract environmentally conscious customers.

Insights:

The atorvastatin generic market in China is expected to continue its growth trajectory in the coming years, driven by the increasing prevalence of cardiovascular diseases and the growing aging population. With the government’s focus on improving healthcare infrastructure and access to affordable medications, the demand for atorvastatin generics is likely to rise. Companies that invest in research and development, as well as sustainable manufacturing practices, are poised to capitalize on this growing market opportunity. As competition intensifies, companies will need to differentiate themselves through product quality, pricing, and innovative marketing strategies to maintain their market share and stay ahead of the competition.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →